Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Net Income Contraction
Modest growth trend.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-7.88M
↑ 11% above average
Average (9y)
$-8.86M
Historical baseline
Range
High:$-4.80M
Low:$-14.44M
CAGR
+5.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-7.88M | -3.2% |
| 2023 | $-7.63M | +25.0% |
| 2022 | $-10.17M | +19.2% |
| 2021 | $-12.60M | +12.8% |
| 2020 | $-14.44M | -14.4% |
| 2019 | $-12.63M | -92.1% |
| 2018 | $-6.57M | -32.2% |
| 2017 | $-4.97M | +28.0% |
| 2016 | $-6.90M | -43.8% |
| 2015 | $-4.80M | - |